Trial
NCT03179956
Impact of Ribociclib on Head and Neck Squamous Cell Cancer
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fox Chase Cancer Center
Collaborators
—
Condition
Squamous Cell Carcinoma of the Head and Neck
Intervention
Ribociclib
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-25